Civica Rx的动态

Do what’s in the best interest of patients.

Hard to believe it's less than a week away - I'll be at the Medical Affairs Professional Society (MAPS) conference next week. Are you or a colleague attending? I'd love to catch up! Whether we've worked together in the past or have been meaning to connect, this is the perfect chance to make it happen and learn more about your 2024 #strategicpriorities! Message me to coordinate or comment below! Amplity Health #medicalaffairs #fieldmedical #strategicpartnerships #pharmaceuticalsolutionspartner #amplityhealth #adultlearning #commercialsolutions #biotech

Patienten Wie Wir e.V. connects patients throughout #Europe with medical #evidence and #innovation on curative #therapies and (even better) #prevention. #medicine #health

?? Exciting News! ?? ?? The 19th BioPharma Clinical Trials Nexus panel is happening right NOW! ?? Join us as we delve into the dynamic world of collaboration between Medical Affairs and Clinical Operations, aimed at enhancing clinical trial efficiency! ?? ?? This insightful panel brings together industry experts to discuss innovative strategies, best practices, and the latest trends shaping the future of clinical trials. Let's revolutionize clinical trials together! ?? #ClinicalTrials #MedicalAffairs #ClinicalOperations #Innovation #Collaboration #Efficiency #BioPharmaNexusConference #Healthcare #Networking #PanelDiscussion #Insights #IndustryTrends ??

"Leave the details to us. Our streamlined research operations mean more efficiency, less hassle, and better outcomes for your clinical trials. Let us support you from start to finish." ?? www.diversitrials.com ??[email protected] #ResearchOperations #ClinicalTrialManagement #StreamlinedProcesses #ResearchExcellence

???? ?????? ???????????????? ???? ???????????????? ?? ?????????? ???????????? ???? ?????? ?????????????????? ????????????????????! Cynthia Girman Founder & CEO, and Mary Beth Ritchey, our new Chief Scientific Officer, are now together at the helm. "Combining our experience, expertise, and skillsets brings synergies that allow us to expand our capabilities and make CERobs the best it can be." Mary Beth rejoined us as Chief Scientific Officer in August 2023, bringing invaluable experience from her role as Chief Epidemiologist at the FDA’s Center for Devices & Radiologic Health. Her leadership and extensive background in pharma, devices, consulting, and the FDA have already made a significant impact on our team. In addition to this leadership shift, we are excited to unveil our refreshed logo and brand identity. We look forward to continuing our global collaborations, offering services in #RealWorldEvidence (RWE), #EvidenceSynthesis, trial #EndpointStrategy (COAs/PROs), clinical #TrialDesign support, and #RegulatoryStrategy for #Medicines and #Devices. Our commitment remains unwavering: to deliver practical, fit-for-purpose #RealWorldSolutionsThatMatter, and generate valuable evidence for patients, physicians, payers, and regulators while upholding the scientific rigor we’re known for. Stay tuned for more updates and connect with us as we embark on this new chapter! #CEROBSConsulting #RWE #EvidenceSynthesis #RWEstrategy #RegulatoryStrategy #RWEforRegulatoryDecisions #COA #PRO #EndpointStrategy

MERIT's clinical operations team provides personalized attention, collaborating closely with our partners to focus on details that drive study milestone achievement and increase site engagement. Learn more: https://lnkd.in/d_m7t7_u #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch #clinicaloperations #projectmanagement

Wanna learn what drugs are #superheroes and #villains to patients? Curious about the #threebodyproblem in healthcare and education? Discover how we used #MAGIC to tackle this problem through #digitalhealthtech, and discover the true meaning of the "art and science" of #pharmacy practice and education! Join me and my esteemed panel Phylaine Toh & Kai Zhen Yap as we sprinkle our #magicalsecrets at this year's Singhealth Duke-NUS Education Conference! #sdec2024

Putting patient first in your daily business interaction. Working as market access manager in Pfizer, I've come to realize that success is not just about achieving business goals or making an impact in the market. It's about something much more profound and meaningful - it's about putting patients at the heart of everything we do. Every day, I am reminded of the humanistic aspect of my work. It's not just about navigating the complexities of the healthcare system or ensuring that our products reach those who need them the most. It's about understanding the challenges patients face and finding ways to address them with empathy and compassion. Being patient-centric is not a buzzword or a mere slogan. It is a mindset that should guide every decision we make, every action we take. It means going beyond the numbers and statistics and truly understanding the impact our work has on individuals and their families. I believe that by prioritizing the needs of patients, we not only contribute to the success of our careers but also make a significant difference in society. When we focus on improving patient outcomes, we create a ripple effect that extends far beyond the confines of our professional lives. In my role, I've witnessed firsthand the transformative power of approaching market access with a patient-centric lens. It's about collaborating with healthcare providers, payers, and policymakers to ensure that patients have access to innovative treatments that can improve their quality of life. This is a quick reminder for all of us, that every single daily business action can effectively enhance patients' lives. #PfizerProud #PatientCentricity #patientsFirst

"What do you consider the biggest challenge for Field Medical?" The responses of the registrants for today's webinar "Unveiling the impact of Field Medical" consistently fall in these 3 categories: ?? 1. Measuring the performance & impact of Field Medical ?? 2. Demonstrating (internal & external) the value of Field Medical ?? 3. Better align customer engagement with Commercial Let's discover what the expert panel has to say about this at 4 PM CET!